SUCLA2P2

Across TCGA pan-cancer cohorts, SUCLA2P2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of SUCLA2P2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where SUCLA2P2 RNA is repressed in tumor relative to normal tissue. In most cancer types SUCLA2P2 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD are the cancer types where SUCLA2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SUCLA2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	−0.010	.033	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

SUCLA2P2–STAD

Open the STAD breakdown →